Results 181 to 190 of about 247,651 (343)
GOES GLM, biased bolides, and debiased distributions
Anthony Ozerov +4 more
openalex +1 more source
A Latent Variable Approach for Causal Effect Estimation Under Misclassified Treatment Assignment. [PDF]
Shang Y, Chiu YH, Kong L.
europepmc +1 more source
Time‐Continuous Prognostic Mapping of Bell's Palsy Using Yanagihara Scores and Electroneurography
This study developed a novel, time‐continuous prognostic mapping for Bell's palsy by integrating longitudinal Yanagihara scores and electroneurography in patients treated with high‐dose corticosteroids. By employing a Bayesian probabilistic approach, this model enables individualized recovery estimation at any clinical time point, overcoming the ...
Shogo N. Watanabe +4 more
wiley +1 more source
Riesame dell'uso e del significato della parola golem in Salmi 139:16, e della radice *glm nei passi collegati.
openaire +1 more source
Acupoint glucocorticoid injection combined with focused ultrasound for granulomatous lobular mastitis: a retrospective study. [PDF]
Wang H, Ning W, Wang H, Li H, Zhang G.
europepmc +1 more source
Underground Lag: Fungal Community and Edaphic Legacies After Disturbance
ABSTRACT Páramos are neotropical mountain ecosystems that regulate water and store large amounts of carbon, but are increasingly degraded by agriculture and grazing. Although native vegetation often recolonizes after abandonment, belowground recovery remains poorly understood.
Wilmer Dajhan Navarrete‐López +6 more
wiley +1 more source
Further analyses of the GLM trends for M. paradoxus and M. capensis
Jean Patricia Glazer +2 more
openalex +1 more source
Beyond Conventional Heating: Unlocking the Synergy Between Microwave Irradiation and pH Control for High-Efficiency Fabrication of Phyto-Copper Oxide Nanoparticles. [PDF]
Alqahtani A +3 more
europepmc +1 more source
Background Primary orthostatic tremor (POT) is a rare hyperkinetic movement disorder with limited and largely ineffective treatment options. Perampanel has been suggested as a therapy, but has so far only been investigated in small studies with short duration.
Wietske A. Babeliowsky +4 more
wiley +1 more source
Abstract Background Leucine‐rich repeat kinase 2 (LRRK2) kinase inhibition is a promising therapeutic strategy for Parkinson's disease (PD), but the functional impact of Asian‐prevalent LRRK2 p.G2385R and p.R1628P variants remains unclear. Robust patient stratification and target engagement markers are needed for global LRRK2‐targeted trials ...
Tzi Shin Toh +17 more
wiley +1 more source

